{
  "DOI": "10.1007/s12687-021-00557-w",
  "ISSN": [
    "1868-310X",
    "1868-6001"
  ],
  "URL": "http://dx.doi.org/10.1007/s12687-021-00557-w",
  "alternative-id": [
    "557"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "22 April 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "6 October 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "29 November 2021"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "This study was approved by the University of British Columbia-BC Cancer Research Ethics Board. Consent to participate was not required for this retrospective study of de-identified administrative data, in accordance with British Columbia’s Freedom of Information and Protection of Privacy Act (FIPPA)."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Consent for publication was not required for this retrospective study of de-identified administrative data, in accordance with British Columbia’s FIPPA."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "Marco A. Marra reports no conflicts of interest. Deirdre Weymann co-directs IMPRINT Research Consulting and has consulted for Roche Canada. Janessa Laskin has received honoraria for academic talks from Roche Canada, Pfizer Canada, Astra-Zeneca Canada, and Eli Lilly Canada; her institution has received research funding for her projects from Roche Canada and Astra-Zeneca Canada. Steven J.M. Jones has received project funding from Roche. Daniel J. Renouf disclosures include research funding and honoraria from Bayer and Roche, and travel funding and honoraria from Servier, Celgene, Taiho, Ipsen, and Astra-Zeneca. Howard J. Lim has received honoraria from Eisai, Taiho, Roche, Lilly, BMS, Amgen, and Leo for consultant work and is an investigator on trials with Bayer, BMS, Lilly, Roche, Astra-Zeneca, and Amgen. Kasmintan Schrader has received research grant and honoraria funding from Astra-Zeneca and Pfizer. Sophie Sun has received research grant and honoraria funding from Astra-Zeneca and honoraria from BMS, Novartis, Pfizer, Purdue, Roche, and Takeda. Stephen Yip is an advisory board member for and has received travel allowance from Amgen, Astra-Zeneca, Bayer, Novartis, and Roche. Dean A. Regier has received honoraria from Roche Canada and Astra-Zeneca."
    },
    {
      "label": "Free to read",
      "name": "free",
      "value": "This content has been made available to all."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Weymann",
      "given": "Deirdre",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Laskin",
      "given": "Janessa",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Jones",
      "given": "Steven J. M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Roscoe",
      "given": "Robyn",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lim",
      "given": "Howard J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Renouf",
      "given": "Daniel J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Schrader",
      "given": "Kasmintan A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sun",
      "given": "Sophie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yip",
      "given": "Stephen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Marra",
      "given": "Marco A.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-8876-0511",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Regier",
      "given": "Dean A.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Journal of Community Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        11,
        29
      ]
    ],
    "date-time": "2021-11-29T10:02:59Z",
    "timestamp": 1638180179000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        10,
        3
      ]
    ],
    "date-time": "2022-10-03T09:30:23Z",
    "timestamp": 1664789423000
  },
  "funder": [
    {
      "DOI": "10.13039/501100000233",
      "award": [
        "B20POG"
      ],
      "doi-asserted-by": "publisher",
      "name": "Genome British Columbia"
    },
    {
      "award": [
        "G05ChS"
      ],
      "name": "Genome British Columbia/Genome Canada"
    },
    {
      "DOI": "10.13039/501100002784",
      "doi-asserted-by": "publisher",
      "name": "Canada Excellence Research Chairs, Government of Canada"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        18
      ]
    ],
    "date-time": "2024-03-18T09:39:07Z",
    "timestamp": 1710754747832
  },
  "is-referenced-by-count": 3,
  "issn-type": [
    {
      "type": "print",
      "value": "1868-310X"
    },
    {
      "type": "electronic",
      "value": "1868-6001"
    }
  ],
  "issue": "5",
  "issued": {
    "date-parts": [
      [
        2021,
        11,
        29
      ]
    ]
  },
  "journal-issue": {
    "issue": "5",
    "published-print": {
      "date-parts": [
        [
          2022,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            11,
            29
          ]
        ],
        "date-time": "2021-11-29T00:00:00Z",
        "timestamp": 1638144000000
      }
    },
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            11,
            29
          ]
        ],
        "date-time": "2021-11-29T00:00:00Z",
        "timestamp": 1638144000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s12687-021-00557-w.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s12687-021-00557-w/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s12687-021-00557-w.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "523-538",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2021,
        11,
        29
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        11,
        29
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1056/NEJMsr1809937",
      "author": "All of Us Research Program Investigators",
      "doi-asserted-by": "publisher",
      "first-page": "668",
      "journal-title": "N Engl J Med",
      "key": "557_CR1",
      "unstructured": "All of Us Research Program Investigators (2019) The “All of Us” research program. N Engl J Med 381:668–676",
      "volume": "381",
      "year": "2019"
    },
    {
      "author": "S Allin",
      "first-page": "83",
      "journal-title": "Healthcare Policy",
      "key": "557_CR2",
      "unstructured": "Allin S (2008) Does equity in healthcare use vary across Canadian provinces? Healthcare Policy 3:83",
      "volume": "3",
      "year": "2008"
    },
    {
      "DOI": "10.1093/biomet/87.2.329",
      "author": "H Bang",
      "doi-asserted-by": "publisher",
      "first-page": "329",
      "journal-title": "Biometrika",
      "key": "557_CR3",
      "unstructured": "Bang H, Tsiatis AA (2000) Estimating medical costs with censored data. Biometrika 87:329–343",
      "volume": "87",
      "year": "2000"
    },
    {
      "DOI": "10.1017/S026646231800048X",
      "author": "A Barna",
      "doi-asserted-by": "publisher",
      "first-page": "368",
      "journal-title": "Int J Technol Assess Health Care",
      "key": "557_CR4",
      "unstructured": "Barna A, Cruz-Sanchez TM, Brigham KB, Thuong C-T, Kristensen FB, Durand-Zaleski I (2018) Evidence required by health technology assessment and reimbursement bodies evaluating diagnostic or prognostic algorithms that include omics data. Int J Technol Assess Health Care 34:368–377",
      "volume": "34",
      "year": "2018"
    },
    {
      "key": "557_CR5",
      "unstructured": "BC Cancer [creator]: BC Cancer Registry Data; BC Ministry of Health [creator]: Medical Services Plan (MSP) payment information file; Discharge Abstracts Database; PharmaNet, Population Data BC [publisher] (n.d.) Data Extract. BC Cancer; MOH; Data Stewardship Committee. Available at http://www.popdata.bc.ca/data"
    },
    {
      "key": "557_CR6",
      "unstructured": "BC Medical Services Commission (2017) MSP payment schedule. Accessed 19 Oct. http://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/msp/physicians/payment-schedules/msc-payment-schedule"
    },
    {
      "DOI": "10.1186/s13073-021-00897-9",
      "author": "F Bertucci",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Genome Med",
      "key": "557_CR7",
      "unstructured": "Bertucci F, Gonçalves A, Guille A, Adelaïde J, Garnier S, Carbuccia N, Billon E, Finetti P, Sfumato P, Monneur A (2021) Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial. Genome Med 13:1–20",
      "volume": "13",
      "year": "2021"
    },
    {
      "key": "557_CR8",
      "unstructured": "British Columbia Cancer (2016) New genetic tests become standard of care in BC. Accessed 21 July 2020. http://www.bccancer.bc.ca/about/news-stories/news/2016/new-genetic-tests-become-standard-of-cancer-care-in-bc"
    },
    {
      "key": "557_CR9",
      "unstructured": "British Columbia Cancer (2018) Chemotherapy protocols. Accessed 01 Jan 2018. http://www.bccancer.bc.ca/health-professionals/professional-resources/chemotherapy-protocols"
    },
    {
      "DOI": "10.1016/j.tips.2016.10.012",
      "author": "DC Collins",
      "doi-asserted-by": "publisher",
      "first-page": "25",
      "journal-title": "Trends Pharmacol Sci",
      "key": "557_CR10",
      "unstructured": "Collins DC, Sundar R, Lim JSJ, Yap TA (2017) Towards precision medicine in the clinic: from biomarker discovery to novel therapeutics. Trends Pharmacol Sci 38:25–40",
      "volume": "38",
      "year": "2017"
    },
    {
      "DOI": "10.14694/EdBook_AM.2015.35.e175",
      "doi-asserted-by": "crossref",
      "key": "557_CR11",
      "unstructured": "Damodaran, S, Berger, MF, Roychowdhury, S (2015) Clinical tumor sequencing: opportunities and challenges for precision cancer medicine. In American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Meeting, e175. NIH Public Access"
    },
    {
      "DOI": "10.1186/s12885-016-2835-7",
      "author": "C de Oliveira",
      "doi-asserted-by": "publisher",
      "first-page": "809",
      "journal-title": "BMC Cancer",
      "key": "557_CR12",
      "unstructured": "de Oliveira C, Pataky R, Bremner KE, Rangrej J, Chan KKW, Cheung WY, Hoch JS, Peacock S, Krahn MD (2016) Phase-specific and lifetime costs of cancer care in Ontario, Canada. BMC Cancer 16:809",
      "volume": "16",
      "year": "2016"
    },
    {
      "DOI": "10.1162/REST_a_00318",
      "author": "A Diamond",
      "doi-asserted-by": "publisher",
      "first-page": "932",
      "journal-title": "Rev Econ Stat",
      "key": "557_CR13",
      "unstructured": "Diamond A, Sekhon JS (2013) Genetic matching for estimating causal effects: a general multivariate matching method for achieving balance in observational studies. Rev Econ Stat 95:932–945",
      "volume": "95",
      "year": "2013"
    },
    {
      "author": "MF Drummond",
      "key": "557_CR14",
      "unstructured": "Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW (2015) Methods for the economic evaluation of health care programmes. Oxford university press",
      "volume-title": "Methods for the economic evaluation of health care programmes",
      "year": "2015"
    },
    {
      "DOI": "10.1080/01621459.1987.10478410",
      "author": "B Efron",
      "doi-asserted-by": "publisher",
      "first-page": "171",
      "journal-title": "J Am Stat Assoc",
      "key": "557_CR15",
      "unstructured": "Efron B (1987) Better bootstrap confidence intervals. J Am Stat Assoc 82:171–185",
      "volume": "82",
      "year": "1987"
    },
    {
      "DOI": "10.1016/j.jval.2012.05.006",
      "author": "E Faulkner",
      "doi-asserted-by": "publisher",
      "first-page": "1162",
      "journal-title": "Value Health",
      "key": "557_CR16",
      "unstructured": "Faulkner E, Annemans L, Garrison L, Helfand M, Holtorf A-P, Hornberger J, Hughes D, Li T, Malone D, Payne K (2012) Challenges in the development and reimbursement of personalized medicine—payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group. Value Health 15:1162–1171",
      "volume": "15",
      "year": "2012"
    },
    {
      "key": "557_CR17",
      "unstructured": "Genomics England  (2017) The 100,000 Genomes Project Protocol. Genomics England. https://www.genomicsengland.co.uk/wp-content/uploads/2017/03/GenomicEnglandProtocol_151117-v4-Wales.pdf. Accessed 11 Feb 2021"
    },
    {
      "DOI": "10.1038/nrg.2016.49",
      "author": "S Goodwin",
      "doi-asserted-by": "publisher",
      "first-page": "333",
      "journal-title": "Nat Rev Genet",
      "key": "557_CR18",
      "unstructured": "Goodwin S, McPherson JD, Richard W, McCombie. (2016) Coming of age: ten years of next-generation sequencing technologies. Nat Rev Genet 17:333",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s40273-017-0509-1",
      "author": "MJ IJzerman",
      "doi-asserted-by": "publisher",
      "first-page": "727",
      "journal-title": "Pharmacoeconomics",
      "key": "557_CR19",
      "unstructured": "IJzerman MJ, Koffijberg H, Fenwick E, Krahn M (2017) Emerging use of early health technology assessment in medical product development: a scoping review of the literature. Pharmacoeconomics 35:727–740",
      "volume": "35",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.eururo.2014.08.061",
      "author": "SL Jarosek",
      "doi-asserted-by": "publisher",
      "first-page": "273",
      "journal-title": "Eur Urol",
      "key": "557_CR20",
      "unstructured": "Jarosek SL, Virnig BA, Chu H, Elliott SP (2015) Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both. Eur Urol 67:273–280",
      "volume": "67",
      "year": "2015"
    },
    {
      "DOI": "10.1080/01621459.1958.10501452",
      "author": "EL Kaplan",
      "doi-asserted-by": "publisher",
      "first-page": "457",
      "journal-title": "J Am Stat Assoc",
      "key": "557_CR21",
      "unstructured": "Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481",
      "volume": "53",
      "year": "1958"
    },
    {
      "DOI": "10.1186/1471-2407-14-586",
      "author": "S Khor",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "BMC Cancer",
      "key": "557_CR22",
      "unstructured": "Khor S, Beca J, Krahn M, Hodgson D, Lee L, Crump M, Bremner KE, Luo J, Mamdani M, Bell CM (2014) Real world costs and cost-effectiveness of rituximab for diffuse large B-cell lymphoma patients: a population-based analysis. BMC Cancer 14:1–11",
      "volume": "14",
      "year": "2014"
    },
    {
      "author": "A Kolmogorov",
      "first-page": "461",
      "journal-title": "Giornalo dell’Istituto Italiano degli Attuari",
      "key": "557_CR23",
      "unstructured": "Kolmogorov A (1933) Sulla determinazione empirica di una legge di distribuzione. Giornalo dell’Istituto Italiano degli Attuari 4:461",
      "volume": "4",
      "year": "1933"
    },
    {
      "DOI": "10.1101/mcs.a000570",
      "author": "J Laskin",
      "doi-asserted-by": "publisher",
      "first-page": "a000570",
      "journal-title": "Molec Case Stud",
      "key": "557_CR24",
      "unstructured": "Laskin J, Jones S, Aparicio S, Chia S, Ch'ng C, Deyell R, Eirew P, Fok A, Gelmon K, Ho C (2015) Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers. Molec Case Stud 1:a000570",
      "volume": "1",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.ejphar.2018.07.034",
      "author": "YT Lee",
      "doi-asserted-by": "publisher",
      "first-page": "188",
      "journal-title": "Eur J Pharmacol",
      "key": "557_CR25",
      "unstructured": "Lee YT, Tan YJ, Oon CE (2018) Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol 834:188–196",
      "volume": "834",
      "year": "2018"
    },
    {
      "DOI": "10.1002/sim.1377",
      "author": "DY Lin",
      "doi-asserted-by": "publisher",
      "first-page": "1181",
      "journal-title": "Stat Med",
      "key": "557_CR26",
      "unstructured": "Lin DY (2003) Regression analysis of incomplete medical cost data. Stat Med 22:1181–1200",
      "volume": "22",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.jval.2020.01.017",
      "author": "ZP Mackay",
      "doi-asserted-by": "publisher",
      "first-page": "559",
      "journal-title": "Value Health",
      "key": "557_CR27",
      "unstructured": "Mackay ZP, Dukhovny D, Phillips KA, Beggs AH, Green RC, Parad RB, Christensen KD, Agrawal PB, Ceyhan-Birsoy O, Fayer S (2020) Quantifying downstream healthcare utilization in studies of genomic testing. Value Health 23:559–565",
      "volume": "23",
      "year": "2020"
    },
    {
      "DOI": "10.1158/1538-7445.AM2020-SY09-03",
      "author": "D Malkin",
      "doi-asserted-by": "publisher",
      "key": "557_CR28",
      "unstructured": "Malkin D, Berman JN, Chan JA, Denburg A, Deyell R, Eisenstadt D, Fernandez C, Grover S, Gupta A, Hawkings C (2020) Abstract SY09–03: PROFYLEing Cancer for KiCS: the Canadian pediatric precision oncology initiative. AACR",
      "volume-title": "Abstract SY09–03: PROFYLEing Cancer for KiCS: the Canadian pediatric precision oncology initiative",
      "year": "2020"
    },
    {
      "DOI": "10.2165/00019053-199813030-00002",
      "author": "JA Mauskopf",
      "doi-asserted-by": "publisher",
      "first-page": "277",
      "journal-title": "Pharmacoeconomics",
      "key": "557_CR29",
      "unstructured": "Mauskopf JA, Paul JE, Grant DM, Stergachis A (1998) The role of cost-consequence analysis in healthcare decision-making. Pharmacoeconomics 13:277–288",
      "volume": "13",
      "year": "1998"
    },
    {
      "DOI": "10.1007/s10549-021-06211-w",
      "doi-asserted-by": "crossref",
      "key": "557_CR30",
      "unstructured": "McSorley LM, Tharmabala M, Al Rahbi F, McSorley K, Chew S, Evoy D, Geraghty JG, Prichard RS, Rothwell J, McCartan DP (2021) Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland. Breast Cancer Res Treat:1–10"
    },
    {
      "DOI": "10.1177/0272989X20980327",
      "doi-asserted-by": "crossref",
      "key": "557_CR31",
      "unstructured": "Murphy P, Claxton L, Hodgson R, Glynn D, Beresford L, Walton M, Llewellyn A, Palmer S, Dias S (2021) Exploring heterogeneity in histology-independent technologies and the implications for cost-effectiveness. Medical Decision Making: 0272989X20980327"
    },
    {
      "DOI": "10.1038/s43018-020-0050-6",
      "doi-asserted-by": "crossref",
      "key": "557_CR32",
      "unstructured": "Pleasance, E, Titmuss, E, Williamson, L, Kwan, H, Culibrk, L, Zhao, EY, Dixon, K, Fan, K, Bowlby, R, Jones, MR (2020) Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes. Nature Cancer: 1–17"
    },
    {
      "DOI": "10.1001/jama.2018.9824",
      "author": "CJ Presley",
      "doi-asserted-by": "publisher",
      "first-page": "469",
      "journal-title": "JAMA",
      "key": "557_CR33",
      "unstructured": "Presley CJ, Tang D, Soulos PR, Chiang AC, Longtine JA, Adelson KB, Herbst RS, Zhu W, Nussbaum NC, Sorg RA (2018) Association of broad-based genomic sequencing with survival among patients with advanced non-small cell lung cancer in the community oncology setting. JAMA 320:469–477",
      "volume": "320",
      "year": "2018"
    },
    {
      "author": "RC, Team",
      "key": "557_CR34",
      "unstructured": "RC, Team (2014) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna",
      "volume-title": "R: a language and environment for statistical computing",
      "year": "2014"
    },
    {
      "DOI": "10.1038/s41591-019-0424-4",
      "author": "J Rodon",
      "doi-asserted-by": "publisher",
      "first-page": "751",
      "journal-title": "Nat Med",
      "key": "557_CR35",
      "unstructured": "Rodon J, Soria J-C, Berger R, Miller WH, Rubin E, Kugel A, Tsimberidou A, Saintigny P, Ackerstein A, Braña I (2019) Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial. Nat Med 25:751–758",
      "volume": "25",
      "year": "2019"
    },
    {
      "DOI": "10.1093/biomet/70.1.41",
      "author": "PR Rosenbaum",
      "doi-asserted-by": "publisher",
      "first-page": "41",
      "journal-title": "Biometrika",
      "key": "557_CR36",
      "unstructured": "Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70:41–55",
      "volume": "70",
      "year": "1983"
    },
    {
      "DOI": "10.2307/2533160",
      "doi-asserted-by": "crossref",
      "key": "557_CR37",
      "unstructured": "Rubin DB, Thomas N (1996) Matching using estimated propensity scores: relating theory to practice. Biometrics:249–264"
    },
    {
      "DOI": "10.1371/journal.pone.0189651",
      "author": "SH Sabir",
      "doi-asserted-by": "publisher",
      "first-page": "e0189651",
      "journal-title": "PLoS One",
      "key": "557_CR38",
      "unstructured": "Sabir SH, Krishnamurthy S, Gupta S, Mills GB, Wei W, Cortes AC, Mills KR, Shaw RL, Wallace MJ (2017) Characteristics of percutaneous core biopsies adequate for next generation genomic sequencing. PLoS One 12:e0189651",
      "volume": "12",
      "year": "2017"
    },
    {
      "DOI": "10.1038/gim.2017.247",
      "author": "K Schwarze",
      "doi-asserted-by": "publisher",
      "first-page": "1122",
      "journal-title": "Genet Med",
      "key": "557_CR39",
      "unstructured": "Schwarze K, Buchanan J, Taylor JC, Wordsworth S (2018) Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature. Genet Med 20:1122–1130",
      "volume": "20",
      "year": "2018"
    },
    {
      "author": "NV Smirnov",
      "first-page": "3",
      "journal-title": "Bull Moscow Univ",
      "key": "557_CR40",
      "unstructured": "Smirnov NV (1939) Estimate of deviation between empirical distribution functions in two independent samples. Bull Moscow Univ 2:3–16",
      "volume": "2",
      "year": "1939"
    },
    {
      "author": "E Soysal",
      "first-page": "268",
      "journal-title": "AMIA Summits Translat Sci Proc",
      "key": "557_CR41",
      "unstructured": "Soysal E, Warner JL, Denny JC, Hua X (2017) Identifying metastases-related information from pathology reports of lung cancer patients. AMIA Summits Translat Sci Proc 2017:268",
      "volume": "2017",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.ajhg.2018.11.014",
      "author": "Z Stark",
      "doi-asserted-by": "publisher",
      "first-page": "13",
      "journal-title": "Am J Hum Genet",
      "key": "557_CR42",
      "unstructured": "Stark Z, Dolman L, Manolio TA, Ozenberger B, Hill SL, Caulfied MJ, Levy Y, Glazer D, Wilson J, Lawler M (2019) Integrating genomics into healthcare: a global responsibility. Am J Hum Genet 104:13–20",
      "volume": "104",
      "year": "2019"
    },
    {
      "author": "StataCorp.",
      "key": "557_CR43",
      "unstructured": "StataCorp. (2017) Stata statistical software: release 15. StataCorp LLC, College Station",
      "volume-title": "Stata statistical software: release 15",
      "year": "2017"
    },
    {
      "DOI": "10.1200/JCO.2018.36.15_suppl.6513",
      "author": "LM Steuten",
      "doi-asserted-by": "publisher",
      "key": "557_CR44",
      "unstructured": "Steuten LM, Gertruda BHL, Goulart NJ, Meropol DP, Ramsey SD (2018) Cost-effectiveness of multi-gene panel sequencing (MGPS) for advanced non-small cell lung cancer (aNSCLC) patients. American Society of Clinical Oncology",
      "volume-title": "Cost-effectiveness of multi-gene panel sequencing (MGPS) for advanced non-small cell lung cancer (aNSCLC) patients",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.ejca.2016.02.006",
      "author": "V Tacher",
      "doi-asserted-by": "publisher",
      "first-page": "79",
      "journal-title": "Eur J Cancer",
      "key": "557_CR45",
      "unstructured": "Tacher V, Le Deley M-C, Hollebecque A, Deschamps F, Vielh P, Hakime A, Ileana E, Abedi-Ardekani B, Charpy C, Massard C (2016) Factors associated with success of image-guided tumour biopsies: results from a prospective molecular triage study (MOSCATO-01). Eur J Cancer 59:79–89",
      "volume": "59",
      "year": "2016"
    },
    {
      "DOI": "10.1016/S1470-2045(15)00188-6",
      "author": "L Tourneau",
      "doi-asserted-by": "publisher",
      "first-page": "1324",
      "journal-title": "Lancet Oncol",
      "key": "557_CR46",
      "unstructured": "Tourneau L, Christophe J-PD, Gonçalves A, Gavoille C, Dubot C, Isambert N, Campone M, Trédan O, Massiani M-A, Mauborgne C (2015) Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. Lancet Oncol 16:1324–1334",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.1101/mcs.a002659",
      "author": "ES Tsang",
      "doi-asserted-by": "publisher",
      "first-page": "a002659",
      "journal-title": "Molec Case Stud",
      "key": "557_CR47",
      "unstructured": "Tsang ES, Shen Y, Chooback N, Ho C, Jones M, Renouf DJ, Lim H, Sun S, Yip S, Pleasance E (2019) Clinical outcomes after whole-genome sequencing in patients with metastatic non-small-cell lung cancer. Molec Case Stud 5:a002659",
      "volume": "5",
      "year": "2019"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-18-1780",
      "author": "IV Tuxen",
      "doi-asserted-by": "publisher",
      "first-page": "1239",
      "journal-title": "Clin Cancer Res",
      "key": "557_CR48",
      "unstructured": "Tuxen IV, Rohrberg KS, Oestrup O, Ahlborn LB, Schmidt AY, Spanggaard I, Hasselby JP, Santoni-Rugiu E, Yde CW, Mau-Sørensen M (2019) Copenhagen prospective personalized oncology (COPPO)—clinical utility of using molecular profiling to select patients to phase I trials. Clin Cancer Res 25:1239–1247",
      "volume": "25",
      "year": "2019"
    },
    {
      "DOI": "10.3332/ecancer.2016.683",
      "doi-asserted-by": "crossref",
      "key": "557_CR49",
      "unstructured": "Van Harten, WH, Retèl, VP (2016) Innovations that reach the patient: early health technology assessment and improving the chances of coverage and implementation. ecancermedicalscience, 10"
    },
    {
      "DOI": "10.1007/s40273-021-01010-z",
      "doi-asserted-by": "crossref",
      "key": "557_CR50",
      "unstructured": "Vellekoop, H, Huygens, S, Versteegh, M, Szilberhorn, L, Zelei, T, Nagy, B, Koleva-Kolarova, R, Tsiachristas, A, Wordsworth, S, Mölken, MR-van (2021) Guidance for the harmonisation and improvement of economic evaluations of personalised medicine. Pharmacoeconomics: 1–18"
    },
    {
      "DOI": "10.21203/rs.3.pex-622/v1",
      "doi-asserted-by": "crossref",
      "key": "557_CR51",
      "unstructured": "Voest, E, Verheul, H, Gelderblom, H, van der Velden, D, Hoes, L, van der Wijngaart, H, van Berge Henegouwen, M (2020) The Drug Rediscovery Protocol (DRUP trial): a Dutch national study on behalf of the Center for Personalized Cancer Treatment (CPCT) to facilitate patient access to commercially available, targeted anti-cancer drugs to determine the potential efficacy in treatment of advanced cancers with a known molecular profile"
    },
    {
      "DOI": "10.1038/s41431-018-0203-6",
      "author": "T Vrijenhoek",
      "doi-asserted-by": "publisher",
      "first-page": "1566",
      "journal-title": "Eur J Hum Genet",
      "key": "557_CR52",
      "unstructured": "Vrijenhoek T, Middelburg EM, Monroe GR, van Gassen KLI, Geenen JW, Hövels AM, Knoers NV, Ploos HK, van Amstel, and Gerardus WJ Frederix. (2018) Whole-exome sequencing in intellectual disability; cost before and after a diagnosis. Eur J Hum Genet 26:1566–1571",
      "volume": "26",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.ejca.2012.10.021",
      "author": "AJ Walker",
      "doi-asserted-by": "publisher",
      "first-page": "1404",
      "journal-title": "Eur J Cancer",
      "key": "557_CR53",
      "unstructured": "Walker AJ, Card TR, West J, Crooks C, Grainge MJ (2013) Incidence of venous thromboembolism in patients with cancer – a cohort study using linked United Kingdom databases. Eur J Cancer 49:1404–1413",
      "volume": "49",
      "year": "2013"
    },
    {
      "DOI": "10.1093/jnci/djv134",
      "doi-asserted-by": "crossref",
      "key": "557_CR54",
      "unstructured": "Warren JL, Robin K, Yabroff. (2015) Challenges and opportunities in measuring cancer recurrence in the United States. JNCI: J Natl Cancer Inst 107"
    },
    {
      "DOI": "10.1002/mgg3.281",
      "author": "D Weymann",
      "doi-asserted-by": "publisher",
      "first-page": "251",
      "journal-title": "Molec Genet Genom Med",
      "key": "557_CR55",
      "unstructured": "Weymann D, Laskin J, Roscoe R, Schrader KA, Chia S, Yip S, Cheung WY, Gelmon KA, Karsan A, Renouf DJ (2017) The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers. Molec Genet Genom Med 5:251–260",
      "volume": "5",
      "year": "2017"
    },
    {
      "DOI": "10.1200/CCI.19.00022",
      "author": "D Weymann",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "JCO Clin Cancer Inform",
      "key": "557_CR56",
      "unstructured": "Weymann D, Costa S, Regier DA (2019) Validation of a cyclic algorithm to proxy number of lines of systemic cancer therapy using administrative data. JCO Clin Cancer Inform 3:1–10",
      "volume": "3",
      "year": "2019"
    },
    {
      "DOI": "10.1002/mgg3.1554",
      "doi-asserted-by": "crossref",
      "key": "557_CR57",
      "unstructured": "Weymann, D, Laskin, J, Jones, SJM, Lim, H, Renouf, DJ, Roscoe, R, Schrader, KA, Sun, S, Yip, S, Marra, MA (2020) Matching methods in precision oncology: an introduction and illustrative example. Molec Genet Genom Med: e1554"
    },
    {
      "DOI": "10.1002/sim.1794",
      "author": "AR Willan",
      "doi-asserted-by": "publisher",
      "first-page": "131",
      "journal-title": "Stat Med",
      "key": "557_CR58",
      "unstructured": "Willan AR, Lin DY, Manca A (2005) Regression methods for cost-effectiveness analysis with censored data. Stat Med 24:131–145",
      "volume": "24",
      "year": "2005"
    },
    {
      "DOI": "10.1038/s41591-020-1072-4",
      "author": "M Wong",
      "doi-asserted-by": "publisher",
      "first-page": "1742",
      "journal-title": "Nat Med",
      "key": "557_CR59",
      "unstructured": "Wong M, Mayoh C, Lau LMS, Khuong-Quang D-A, Pinese M, Kumar A, Barahona P, Wilkie EE, Sullivan P, Bowen-James R (2020) Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer. Nat Med 26:1742–1753",
      "volume": "26",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.breast.2020.04.003",
      "author": "A Zambelli",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Breast",
      "key": "557_CR60",
      "unstructured": "Zambelli A, Simoncini E, Giordano M, La Verde N, Farina G, Torri V, Colombo G, Piacentini G, Fotia V, Vassalli L (2020) Prospective observational study on the impact of the 21-gene assay on treatment decisions and resources optimization in breast cancer patients in Lombardy: the BONDX study. Breast 52:1–7",
      "volume": "52",
      "year": "2020"
    },
    {
      "DOI": "10.1038/nm.4333",
      "author": "A Zehir",
      "doi-asserted-by": "publisher",
      "first-page": "703",
      "journal-title": "Nat Med",
      "key": "557_CR61",
      "unstructured": "Zehir A, Benayed R, Shah RH, Syed A, Middha S, Kim HR, Srinivasan P, Gao J, Chakravarty D, Devlin SM (2017) Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med 23:703–713",
      "volume": "23",
      "year": "2017"
    },
    {
      "DOI": "10.1101/cshperspect.a034579",
      "author": "EY Zhao",
      "doi-asserted-by": "publisher",
      "first-page": "a034579",
      "journal-title": "Cold Spring Harbor Perspect Med",
      "key": "557_CR62",
      "unstructured": "Zhao EY, Jones M, Jones SJM (2019) Whole-genome sequencing in cancer. Cold Spring Harbor Perspect Med 9:a034579",
      "volume": "9",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.csbj.2019.03.012",
      "author": "K Zimmer",
      "doi-asserted-by": "publisher",
      "first-page": "447",
      "journal-title": "Comput Struct Biotechnol J",
      "key": "557_CR63",
      "unstructured": "Zimmer K, Kocher F, Spizzo G, Salem M, Gastl G, Seeber A (2019) Treatment according to molecular profiling in relapsed/refractory cancer patients: a review focusing on latest profiling studies. Comput Struct Biotechnol J 17:447–453",
      "volume": "17",
      "year": "2019"
    }
  ],
  "reference-count": 63,
  "references-count": 63,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s12687-021-00557-w"
    }
  },
  "score": 0,
  "short-container-title": [
    "J Community Genet"
  ],
  "source": "Crossref",
  "title": [
    "Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "13"
}